openPR Logo
Press release

Global Neurostimulation Market 2018 Key Country Analysis - NDI, NeuroPace, Johnson & Johnson, Cogentix Medical, Neuronetics, MED-EL, Cochlear Limited, LivaNova PLC, Boston Scientific, Others

07-09-2018 12:42 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

"Neurostimulation"

"Neurostimulation"

The neurostimulation market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.

Get Free Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-neurostimulation-market

Report Analysis:

The Global Neurostimulation Market accounted to USD 6,475.03 million in 2016 growing at a CAGR of 13.2% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Report Definition:

Neurostimulation is the process which provides mild electrical pulses to your spine, causing a tingling sensation in the area of your chronic pain. It is used for the treatment of various unbearable conditions such as gastroparesis, incontinence, Parkinson’s disease, epilepsy, depression and essential tremors. Neurostimulation is a highly probable treatment option for patients who do not attain relief from medications and surgical therapies. Increased in the chronic diseases such as migraine and epilepsy boosts the market growth.

Company Share Analysis:

The Neurostimulation Market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of neurostimulation market for global, Europe, North America, Asia Pacific and South America.

Top Companies Mentioned:

• Medtronic
• Abbott
• Boston Scientific Corporation
• LivaNova PLC
• Cochlear Ltd.
• MED-EL
• Nevro Corp.
• Neuronetics
• Cogentix Medical
• Johnson & Johnson Services Inc.
• NeuroPace, Inc.
• NeuroSigma, Inc.
• NDI
• IntraPace, Inc.
• BioControl Medical
• Synapse Biomedical Inc.
• Biegler GmbH
• Stimwave LLC
• Modulus, Inc.
• Integer Holdings Corporation

This report consists of below pages:

• No of pages: 350
• No of Figures: 60
• No of Tables: 220

Order a copy of Global Neurostimulation Market Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-neurostimulation-market

Report Segmentation:

The global neurostimulation market is segmented by device type into:

• Implantable Device
• External Device

Implantable device are sub segmented into:

• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Gastric Electric Stimulators

External device are sub segmented into:

• Transcutaneous Electrical Nerve Stimulation
• Transcranial Magnetic Stimulation

By Application the market is segmented into:

• Pain Managemen
• Epilepsy
• Essential Tremor
• Urinary & Fecal Incontinence
• Depression
• Dystonia
• Gastroparesis
• Parkinson’s Disease

On the basis of geography:

• North America
• South America
• Europe
• Asia-Pacific
• Middle East & Africa

Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Research Methodology:

o Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or drop down your inquiry.

o Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

o Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Frequently Asked Questions:

• What will the market size be in 2024?
• What are the key factors driving the global market?
• What are the challenges to market growth?
• Who are the key players in the market?
• What are the market opportunities and threats faced by the key players?
• What will be the growth rate in 2024?
• Which strategies are used by top players in the Global Neurostimulation Market?

View Full Report @ https://databridgemarketresearch.com/reports/global-neurostimulation-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Neurostimulation Market 2018 Key Country Analysis - NDI, NeuroPace, Johnson & Johnson, Cogentix Medical, Neuronetics, MED-EL, Cochlear Limited, LivaNova PLC, Boston Scientific, Others here

News-ID: 1115721 • Views: 443

More Releases from Data Bridge Market Research

Cable Assembly Market Quantitative Analysis By TE Connectivity, Molex, LLC, W. L …
The cable assembly report aids in achieving an extreme sense of evolving industry movements before the competitors. This market research report gives clear idea about strategic analysis of mergers, expansions, acquisitions, partnerships, and investment. It becomes easy to analyse the actions of key players and its effect on the sales, import, export, revenue and CAGR values with this cable assembly report. The report is also a helpful source of assistance
Aroma Chemicals Market 2019:Quantitative Analysis By Hindustan Mint & Agro Produ …
The market analysis of aroma chemicals market report provides an examination of various market segments that are supposed to witness the fastest development amid the estimated forecast frame. A comprehensive market research has been conducted in this report which puts a light on the challenges, market structures, opportunities, driving forces, scope, and competitive landscape for your business. The best tools have been adopted to generate this report which is SWOT
Industrial Communication Market 2019:Industry Analysis By OMRON Corporation, Sch …
Global industrial communication market is set to witness a healthy CAGR of 11.12% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing adoption of industrial internet of things and increasing demand for wireless networks are the factor for the growth of this market. Industrial communication report is a well-generated market report which helps achieve comprehensive analysis of the market
Global Graves Disease Treatment Market­ 2019:Analysis By ALLERGAN, Novartis AG, …
The Graves disease treatment report endows with current and upcoming technical and financial details of the industry to 2025 and hence proves to be a valuable source of information. The report can be accessible to the users in the form of PDF or spreadsheet. Moreover, PPT format can also be offered depending upon client’s requirement. Further, the statistical and numerical data including facts and figures are characterized very properly with

All 5 Releases


More Releases for Neurostimulation

Neurostimulation Device Market Opportunity Assessment Study - P&S Intelligence
The neurostimulation device market is growing, due to increasing geriatric population, increasing prevalence of chronic pain, and increasing incidents of neurological disorders. In addition, the awareness about mental diseases and their treatment is also increasing across the globe. Explore Report with Detailed TOC on “Global Neurostimulation Device Market” at: https://www.psmarketresearch.com/market-analysis/neurostimulation-devices-market The information and data in the publication “Global Neurostimulation Device Market Size, Share, Development, Growth and Demand Forecast to 2022” represent the
Neurostimulation Market Forecast Research Reports Offers Key Insights 2025
Neurostimulation is used for the treatment of various debilitating conditions such as gastroparesis, incontinence, Parkinson’s disease, epilepsy, depression and essential tremors. Neurostimulation is a highly potential treatment option for patients who do not obtain relief from medications and surgical therapies. It improves the quality of life of patients who are severely paralyzed or suffering from intense loss of various sense organs. Therefore, neurostimulation is highly instrumental in artificial vision, hearing
Global Neurostimulation Devices Market overview
Neurostimulation devices are commonly used to diagnose and treat disorders of the autonomic nervous system, the central nervous system (CNS) and the peripheral nervous system (PNS). Neurostimulation devices are used to stimulate brain cells and administer medications. Diseases that do not respond to routine pharmacological treatments require advanced stimulation devices to treat them. The demand for such devices is increasing, particularly for the treatment of chronic neurological conditions such as
Neurostimulation Market Boosting the Healthcare Industry Worldwide
Driven by rising health awareness and continuous disruptive innovations made in the field of medical and biological technologies, the global market for neurostimulation is expected to reach a market size valued at USD 7.3 billion in year 2018. The market is expected to grow at a healthy CAGR of 8.2% from 2012 – 2018. It was estimated at USD 4.2 billion in 2011. View Report: https://www.transparencymarketresearch.com/neurostimulation-market.html Medical devices manufacturing companies and their
Neurostimulation Devices Market - Opportunity Analysis, 2016–2025
Neurostimulation therapy is used for treatment and diagnosis of nervous disorder. It reduces chronic pain associated with conditions such as Parkinson’s disease, epilepsy, nociceptive pain, neuropathic pain, and depression. It helps to improve quality of life of patients suffering from paralysis, obesity, and severe loss of sensory organs. Neurostimulation devices is a key element used in neural prosthetics for artificial vision, artificial limbs, and hearing aids. They include implantable and
Neurostimulation Market Forecast and Segments, 2012 - 2018
Driven by rising health awareness and continuous disruptive innovations made in the field of medical and biological technologies, the global market for neurostimulation is expected to reach a market size valued at USD 7.3 billion in year 2018. The market is expected to grow at a healthy CAGR of 8.2% from 2012 – 2018. It was estimated at USD 4.2 billion in 2011. Medical devices manufacturing companies and their technological affiliates